Gemfibrozil and Tinnitus - a phase IV clinical study of FDA data

Summary:

Tinnitus is reported as a side effect among people who take Gemfibrozil (gemfibrozil), especially for people who are male, 60+ old, have been taking the drug for 1 - 6 months also take Zometa, and have High blood pressure.

The phase IV clinical study analyzes which people have Tinnitus when taking Gemfibrozil. It is created by eHealthMe based on reports of 17,763 people who have side effects when taking Gemfibrozil from the FDA, and is updated regularly.

What is Gemfibrozil?

Gemfibrozil has active ingredients of gemfibrozil. It is often used in high blood cholesterol. eHealthMe is studying from 18,213 Gemfibrozil users. Check the latest studies of Gemfibrozil.

What is Tinnitus?

Tinnitus (a ringing in the ears) is found to be associated with 1,669 drugs and 3,060 conditions by eHealthMe. Check the latest studies of Tinnitus.

On Jul, 13, 2026

17,763 people reported to have side effects when taking Gemfibrozil.
Among them, 98 people (0.55%) have Tinnitus.

Among these 98 people:

How long have people been on Gemfibrozil when they have Tinnitus? *

What is the gender of people who have Tinnitus when taking Gemfibrozil? *

female: 28.57 %
male: 71.43 %

What is the age of people who have Tinnitus when taking Gemfibrozil? *

What are other drugs people take besides Gemfibrozil? *

What are other side effects people have besides Tinnitus? *

Hypoaesthesia (reduced sense of touch or sensation): 46 people, 46.94%
Depression: 46 people, 46.94%
Dizziness: 44 people, 44.90%
Diarrhea: 42 people, 42.86%
Joint Pain: 41 people, 41.84%
Chest Pain: 40 people, 40.82%
Cough: 39 people, 39.80%
Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 39 people, 39.80%
Dyspnea (difficult or laboured breathing): 38 people, 38.78%
Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect): 37 people, 37.76%

What are the existing conditions these people have? *

High Blood Pressure: 30 people, 30.61%
Multiple Myeloma (cancer of the plasma cells): 26 people, 26.53%
Joint Pain: 25 people, 25.51%
Diarrhea: 25 people, 25.51%
Mood Swings (an extreme or rapid change in mood): 25 people, 25.51%
Fluid Retention (an abnormal accumulation of fluid in the blood): 25 people, 25.51%
Seborrhoeic Dermatitis (a common, inflammatory skin condition that causes flaky, white to yellowish scales to form on oily areas such as the scalp): 25 people, 25.51%
Seasonal Allergy (allergic condition due to certain season): 18 people, 18.37%
Blood Triglycerides Decreased: 18 people, 18.37%
Pain: 9 people, 9.18%

* Approximation only. Some reports may have incomplete information.

Do you take Gemfibrozil and have Tinnitus?

- Check whether Tinnitus is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Gemfibrozil:

Gemfibrozil (18,213 reports)

Tinnitus treatments and more:

Tinnitus (58,552 reports)

Browse all side effects of Gemfibrozil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Tinnitus:

Tinnitus (1,669 drugs)

Browse all the conditions that are associated with Tinnitus:

Tinnitus (3,060 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on gemfibrozil (the active ingredients of Gemfibrozil) and Gemfibrozil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.